Page 71 - AN-3-2
P. 71

Advanced Neurology                                             Inflammation in diabetic stroke: Treatment target



            16.  Patoulias DI, Boulmpou A, Teperikidis E,  et al.   study. BMC Endocr Disord. 2020;20(1):31.
               Cardiovascular efficacy and safety of dipeptidyl peptidase-4      doi: 10.1186/s12902-020-0511-z
               inhibitors: A meta-analysis of cardiovascular outcome trials.
               World J Cardiol. 2021;13(10):585-592.           27.  Zhao S, Kusminski CM, Elmquist JK, Scherer PE. Leptin:
                                                                  Less is more. Diabetes. 2020;69(5):823-829.
               doi: 10.4330/wjc.v13.i10.585
                                                                  doi: 10.2337/dbi19-0018
            17.  Schmidt AM. Diabetes mellitus and cardiovascular disease.
               Arterioscler Thromb Vasc Biol. 2019;39(4):558-568.  28.  Cioffi JA, Shafer AW, Zupancic TJ,  et al. Novel B219/OB
                                                                  receptor isoforms: Possible role of leptin in hematopoiesis
               doi: 10.1161/ATVBAHA.119.310961
                                                                  and reproduction. Nat Med. 1996;2(5):585-589.
            18.  Xia  C, Goud  A, D’Souza  J,  et al. DPP4  inhibitors and      doi: 10.1038/nm0596-585
               cardiovascular outcomes: Safety on heart failure. Heart Fail
               Rev. 2017;22(3):299-304.                        29.  Sanchez-Margalet  V,  Martin-Romero  C,  Santos-Alvarez  J,
                                                                  Goberna R, Najib S, Gonzalez-Yanes C. Role of leptin as an
               doi: 10.1007/s10741-017-9617-4
                                                                  immunomodulator of blood mononuclear cells: Mechanisms
            19.  Frak W, Hajdys J, Radzioch E, et al. Cardiovascular diseases:   of action. Clin Exp Immunol. 2003;133(1):11-19.
               Therapeutic  potential  of  SGLT-2  inhibitors.  Biomedicines.      doi: 10.1046/j.1365-2249.2003.02190.x
               2023;11(7):2085.
                                                               30.  Nakata M, Yada T, Soejima N, Maruyama I. Leptin promotes
               doi: 10.3390/biomedicines11072085
                                                                  aggregation of human platelets via the long form of its
            20.  Huang K, Luo X, Liao B, Li G, Feng J. Insights into SGLT2   receptor. Diabetes. 1999;48(2):426-429.
               inhibitor treatment of diabetic cardiomyopathy: Focus on      doi: 10.2337/diabetes.48.2.426
               the mechanisms. Cardiovasc Diabetol. 2023;22(1):86.
                                                               31.  Abderrazak A, Syrovets T, Couchie D,  et al. NLRP3
               doi: 10.1186/s12933-023-01816-5
                                                                  inflammasome: From a danger signal sensor to a regulatory
            21.  Gourdy P, Darmon P, Dievart F, Halimi JM, Guerci B.   node of oxidative stress and inflammatory diseases. Redox
               Combining glucagon-like peptide-1 receptor agonists   Biol. 2015;4:296-307.
               (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors      doi: 10.1016/j.redox.2015.01.008
               (SGLT2is) in patients with type 2 diabetes mellitus (T2DM).
               Cardiovasc Diabetol. 2023;22(1):79.             32.  Look AHEAD Research Group, Gregg E, Jakicic J,  et al.
                                                                  Association of the magnitude of weight loss and changes
               doi: 10.1186/s12933-023-01798-4
                                                                  in physical fitness with  long-term  cardiovascular disease
            22.  Eckel RH, Bornfeldt KE, Goldberg IJ. Cardiovascular   outcomes in overweight or obese people with type 2 diabetes:
               disease in diabetes, beyond glucose.  Cell Metab.   A post-hoc analysis of the Look AHEAD randomised clinical
               2021;33(8):1519-1545.                              trial. Lancet Diabetes Endocrinol. 2016;4(11):913-921.
               doi: 10.1016/j.cmet.2021.07.001                    doi: 10.1016/S2213-8587(16)30162-0
            23.  Paridari P, Jabermoradi S, Gholamzadeh R,  et al. Can   33.  Zhao S, Zhu Y, Schultz RD, et al. Partial leptin reduction as
               metformin use reduce the risk of stroke in diabetic patients?   an insulin sensitization and weight loss strategy. Cell Metab.
               A systematic review and meta-analysis.  Diabetes Metab   2019;30(4):706-719.e6.
               Syndr. Feb 2023;17(2):102721.
                                                                  doi: 10.1016/j.cmet.2019.08.005
               doi: 10.1016/j.dsx.2023.102721
                                                               34.  Civitarese AE, Jenkinson CP, Richardson D,  et al.
            24.  Nakatsuji H, Kobayashi H, Kishida K,  et al. Binding   Adiponectin receptors gene expression and insulin
               of adiponectin and C1q in human serum, and clinical   sensitivity in non-diabetic Mexican Americans with or
               significance of the measurement of C1q-adiponectin/total   without a family history of Type 2 diabetes. Diabetologia.
               adiponectin ratio. Metabolism. 2013;62(1):109-120.  2004;47(5):816-820.
               doi: 10.1016/j.metabol.2012.06.006                 doi: 10.1007/s00125-004-1359-x
            25.  Gairolla J,  Kler R,  Modi M, Khurana  D. Leptin  and   35.  Bluher M, Bullen JW Jr., Lee JH, et al. Circulating adiponectin
               adiponectin:  pathophysiological  role  and  possible  and expression of adiponectin receptors in human skeletal
               therapeutic target of inflammation in ischemic stroke. Rev   muscle: Associations with metabolic parameters and
               Neurosci. 2017;28(3):295-306.                      insulin resistance and regulation by physical training. J Clin
                                                                  Endocrinol Metab. 2006;91(6):2310-2316.
               doi: 10.1515/revneuro-2016-0055
                                                                  doi: 10.1210/jc.2005-2556
            26.  Bidulescu A, Dinh PC Jr., Sarwary S, et al. Associations of
               leptin and adiponectin with incident type  2 diabetes and   36.  Bodles AM, Banga A, Rasouli N, Ono F, Kern PA, Owens RJ.
               interactions among African Americans: The Jackson heart   Pioglitazone increases secretion of high-molecular-weight


            Volume 3 Issue 2 (2024)                         10                               doi: 10.36922/an.1694
   66   67   68   69   70   71   72   73   74   75   76